AG真人官方

STOCK TITAN

NorthView Acquisition Corp SEC Filings

PFSA NASDAQ

Welcome to our dedicated page for NorthView Acquisition SEC filings (Ticker: PFSA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NorthView Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NorthView Acquisition's regulatory disclosures and financial reporting.

Filing
Rhea-AI Summary

Schedule 13G filed 24-Jul-2025 shows a group comprised of Ascent Partners Fund LLC, Dominion Capital and related entities plus individuals Mikhail Gurevich, Gennadiy Gurevich and Alon Brenner collectively own 3,359,068 Profusa (PFSA) common shares, equal to 9.99 % of shares outstanding as of 11-Jul-2025. The stake includes up to 820,475 shares issuable on conversion of a convertible promissory note; the note carries a 9.99 % ownership 鈥渂locker,鈥� limiting additional conversions. All voting and dispositive power is reported as shared; no party claims sole control.

The percentage is calculated against the company鈥檚 32,788,877 shares outstanding disclosed in a 18-Jul-2025 8-K. Because the filing is on Form 13G rather than 13D, the group certifies the position is passive and not intended to influence control. Exhibit 1 contains a joint filing agreement. The presence of an institutional investor group near the 10 % threshold signals outside confidence but also points to potential future dilution should the remaining note principal be converted once the blocker is lifted or expires.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.32%
Tags
insider

FAQ

What is the current stock price of NorthView Acquisition (PFSA)?

The current stock price of NorthView Acquisition (PFSA) is $0.466 as of August 8, 2025.

What is the market cap of NorthView Acquisition (PFSA)?

The market cap of NorthView Acquisition (PFSA) is approximately 16.0M.
NorthView Acquisition Corp

NASDAQ:PFSA

PFSA Rankings

PFSA Stock Data

16.02M
24.70M
24.67%
1.16%
0.54%
Medical Devices
Surgical & Medical Instruments & Apparatus
United States
NEW YORK